ENLACAN Trademark

Trademark Overview

On Friday, July 24, 2009, a trademark application was filed for ENLACAN with the United States Patent and Trademark Office. The USPTO has given the ENLACAN trademark a serial number of 77788933. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 28, 2017. This trademark is owned by CSL Behring GmbH. The ENLACAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of blood or bleeding disorders; pharmaceutical preparations for the treatment of deficiencies of blood coagulation; blood proteins, namely, blood Factor XIII for the treatment of blood or bleeding disorders
enlacan

General Information

Serial Number77788933
Word MarkENLACAN
Filing DateFriday, July 24, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 28, 2017
Registration Number3849412
Registration DateTuesday, September 21, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 6, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of blood or bleeding disorders; pharmaceutical preparations for the treatment of deficiencies of blood coagulation; blood proteins, namely, blood Factor XIII for the treatment of blood or bleeding disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 28, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCSL Behring GmbH
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMarburg 35041
DE
Party NameCSL Behring GmbH
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMarburg 35041
DE
Party NameCSL Behring GmbH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMarburg 35041
DE

Trademark Events

Event DateEvent Description
Friday, April 28, 2017CANCELLED SEC. 8 (6-YR)
Wednesday, July 6, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 6, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 21, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, September 21, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 21, 2010REGISTERED-PRINCIPAL REGISTER
Wednesday, July 14, 2010CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Monday, July 12, 2010ASSIGNED TO PETITION STAFF
Thursday, July 8, 2010TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, July 6, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 6, 2010PUBLISHED FOR OPPOSITION
Wednesday, June 2, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 2, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 2, 2010EXAMINER'S AMENDMENT ENTERED
Wednesday, June 2, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 2, 2010EXAMINERS AMENDMENT E-MAILED
Wednesday, June 2, 2010EXAMINERS AMENDMENT -WRITTEN
Friday, April 23, 2010AMENDMENT FROM APPLICANT ENTERED
Friday, April 23, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 23, 2010ASSIGNED TO LIE
Monday, April 12, 2010PAPER RECEIVED
Thursday, October 29, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 29, 2009NON-FINAL ACTION E-MAILED
Thursday, October 29, 2009NON-FINAL ACTION WRITTEN
Tuesday, October 27, 2009ASSIGNED TO EXAMINER
Thursday, September 3, 2009APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 2, 2009ASSIGNED TO LIE
Monday, August 31, 2009PAPER RECEIVED
Tuesday, July 28, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 28, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

enlacan blood treatment pharmaceutical bleeding disorders preparations factor xiii namely coagulation